Physician profile

Morad Askari

Surgery of the Hand (Plastic Surgery) · Coral Gables, FL

NPI 1174715551

$36,248.84

in general payments reported to CMS, 2019-2025

40 companies · $2,629 in 2025

The $2,629 reported for 2025 was more than what 89% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,970.84
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$5,000.00
Travel and Lodging$1,098.11
Entertainment$96.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kerecis Limited $9,070.72 2021-2024 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Arthrex, INC. $5,478.30 2019-2020
Integra Lifesciences Corporation $5,127.60 2019-2025 Biodoptix, Biofix, Medihoney
Kci USA, INC. $2,811.90 2019-2020
Allergan, INC. $2,665.88 2019-2022
Abbvie INC. $1,848.97 2023-2025 Natrelle Saline-Filled Breast Implants, Alloderm
Musculoskeletal Transplant Foundation INC. $1,430.54 2021-2025
Tela Bio, INC. $1,375.98 2019-2025 Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s
Smith+Nephew, INC. $1,205.56 2020-2025 Oasis, Grafix Pl, Versajet
Mentor Worldwide LLC $1,026.21 2021-2025 Mentor Memorygel Resterilizable Gel Sizer
Axogen $579.43 2019-2025 Avance Nerve Graft
Sientra, INC. $569.43 2020-2022
Motiva USA, LLC $365.95 2025
Polynovo North America LLC $294.82 2023-2024 Novosorb Btm
Sanara Medtech INC. $280.31 2023 Celleraterx
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Aroa Biosurgery Incorporated $214.66 2023-2024
Becton, Dickinson and Company $181.07 2025 Galaflex
Tepha INC $170.35 2019
Pacira Pharmaceuticals Incorporated $155.84 2019-2024 Exparel
Treace Medical Concepts, INC. $150.11 2025
Tei Medical INC. $145.06 2019
Stryker Corporation $134.49 2024 Salvation
Acera Surgical, INC. $130.99 2022
Melinta Therapeutics, LLC $121.87 2019
Zimmer Biomet Holdings, INC. $108.67 2019
Organogenesis INC. $99.98 2020
Avita Medical Americas, LLC $96.65 2023 Recell
Galderma Laboratories, L.P. $85.01 2024
Polarityte, INC. $44.54 2019
Misonix INC $43.52 2019-2020
Biotissue Holdings INC. $30.77 2025
Trice Medical, INC. $29.49 2025
Bard Peripheral Vascular, INC. $29.46 2021
Vapotherm INC $25.59 2022
Checkpoint Surgical, INC $24.92 2025 Checkpoint Stimulators
Next Science LLC $24.68 2024 Blastx, Xperience, Surgx
Acell, INC. $21.50 2020
Davol INC. $19.59 2022
Kowa Pharmaceuticals America, INC. $15.56 2023 Seglentis
Sonex Health, INC. $12.87 2024 Sx-One Microknife

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Morad Askari

$36,248.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Kerecis Limited
Context
The $2,629 reported for 2025 was more than what 89% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).

https://glasscript.com/doctor/98793/morad-askari

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.